Dosing algorithms for vitamin K antagonists across VKORC1 and CYP2C9 genotypes.

导出原文传递

翻译打印收藏纠错

第一作者： E V,Baranova

第一单位： Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, the Netherlands.

作者： E V,Baranova ^[1] ; T I,Verhoef ^[2] ; G,Ragia ^[3] ; S,le Cessie ^[4] ; F W,Asselbergs ^[5] ; A,de Boer ^[1] ; V G,Manolopoulos ^[3] ; A H,Maitland-van der Zee ^[6] ; EU-PACT group

作者单位： Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, the Netherlands. ^[1] Department of Applied Health Research, University College London, London, UK. ^[2] Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece. ^[3] Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, the Netherlands.;Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands. ^[4] Department of Cardiology, Division Heart and Lungs, University Medical Center Utrecht, Utrecht, the Netherlands.;Durrer Center for Cardiogenetic Research, ICIN-Netherlands Heart Institute, Utrecht, the Netherlands.;Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, London, UK. ^[5] Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, the Netherlands.;Department of Respiratory Diseases, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. ^[6]

关键词 acenocoumarol drug dosing biomarkers pharmacogenetics phenprocoumon randomized controlled trial